# Biodexa Pharmaceuticals Plc: Form 20-F for the period ended Dec 31, 2021

- Company: [Biodexa Pharmaceuticals Plc](/companies/bdrx.md) (CIK 1643918)
- Form: 20-F
- Filed: 2022-04-26
- Accepted by EDGAR: Apr 26, 2022, 07:21 ET
- Period: 2021-12-31
- Accession: 0001214659-22-005798
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1643918/000121465922005798/m33122020f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1643918/000121465922005798/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Shares outstanding | at 2021-12-31 | 98,468,387 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1643918/000121465922005798/m33122020f.htm

Filed Apr 26, 2022.
Source: SEC EDGAR, the filing index for accession 0001214659-22-005798. Last ingested by Listed: Nov 9, 2026, 17:57 ET. No prices; not investment advice.
